Literature DB >> 25805302

High frequency of adverse reactions and discontinuation with benznidazole treatment for chronic Chagas disease in Milan, Italy.

Spinello Antinori1, Romualdo Grande2, Roberto Bianco3, Letizia Traversi1, Chiara Cogliati4, Daniela Torzillo4, Ernestina Repetto5, Mario Corbellino1, Laura Milazzo1, Massimo Galli1, Laura Galimberti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25805302     DOI： 10.1093/cid/civ230

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.

Authors:  Jerónimo L Ulloa; Renata Spina; Agustina Casasco; Patricia B Petray; Virginia Martino; Miguel A Sosa; Fernanda M Frank; Liliana V Muschietti
Journal:  Parasit Vectors       Date:  2017-11-13       Impact factor: 3.876

2.  Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease.

Authors:  Mario J Olivera; Zulma M Cucunubá; Carlos A Valencia-Hernández; Rafael Herazo; Diana Agreda-Rudenko; Carolina Flórez; Sofía Duque; Rubén S Nicholls
Journal:  PLoS One       Date:  2017-09-26       Impact factor: 3.240

3.  Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis.

Authors:  Clara Crespillo-Andújar; Emmanuele Venanzi-Rullo; Rogelio López-Vélez; Begoña Monge-Maillo; Francesca Norman; Ana López-Polín; José A Pérez-Molina
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.228

4.  Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box.

Authors:  Juan Cantizani; Pablo Gamallo; Ignacio Cotillo; Raquel Alvarez-Velilla; Julio Martin
Journal:  PLoS Negl Trop Dis       Date:  2021-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.